Impacto de la pandemia por COVID-19 en el control lipídico de pacientes que inician inhibidores de la PCSK9-Reference-Cited by-同舟云学术

Impacto de la pandemia por COVID-19 en el control lipídico de pacientes que inician inhibidores de la PCSK9

Published:2022-09 Issue:5 Volume:34 Page:245-252
ISSN:0214-9168
Container-title:Clínica e Investigación en Arteriosclerosis
language:es
Short-container-title:Clínica e Investigación en Arteriosclerosis

Author:

Seijas-Amigo Jose,Gayoso-Rey Mónica,Mauriz-Montero María José,Suarez-Artime Pedro,Casas-Martinez Antonia,Dominguez-Guerra María,Gonzalez-Freire Lara,Estany-Gestal Ana,Codero-Fort Alberto,Rodriguez-Mañero Moisés,Gonzalez-Juanatey Jose Ramón

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

2. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS);Mach;Eur Heart J,2020

4. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

5. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events;Sabatine;N Engl J Med,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare professionals’ perspectives on the use of PCSK9 inhibitors in cardiovascular disease: an in-depth qualitative study;European Journal of Cardiovascular Nursing;2024-05-24

2. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14

3. Patients' perceptions on the facilitators and barriers using injectable therapies in dyslipidaemia: An empirical qualitative descriptive international study;Journal of Advanced Nursing;2023-06-27